Table 1.
Clinicopathologic and Demographic Information
| n = 459 | Mean | SD |
|---|---|---|
| Age, years | 63.4 | 8.2 |
| Pre-PSA, ng/cc | 9.7 | 14.0 |
| PSA, n (%) | ||
| <5 | 116.0 | 25 |
| 5–10 | 212.0 | 46 |
| >10 | 122.0 | 27 |
| AUA | 9.0 | 7.2 |
| Bother | 1.8 | 1.5 |
| IIEF-5, n (%) | ||
| 22–25 | 220.0 | 48 |
| 15–21 | 127.0 | 28 |
| Height, lbs | 70.4 | 2.9 |
| Weight, inches | 191.9 | 31.8 |
| BMI | 27.1 | 3.9 |
| EBL | 87.5 | 33.5 |
| Prost Wt, g | 54.9 | 21.1 |
| pGS, n (%) | ||
| ≤3 + 3 | 90.0 | 20 |
| 3 + 4 | 153.0 | 33 |
| 4 + 3 | 110.0 | 24 |
| 4 + 4 | 28.0 | 6 |
| 3 + 5 | 1.0 | 0 |
| ≥4 + 5 | 61.0 | 13 |
| P-stage, n (%) | ||
| pT2 | 286.0 | 62 |
| pT3/T4 | 161.0 | 35 |
AUA = American Urological Association; BMI = body mass index; EBL = estimated blood loss; pGS = pathologic Gleason score; PSA = prostate-specific antigen; SD = standard deviation; IIEF-5 = international index of erectile function.